Inventor · disambiguated record
Frank Sieg
Also filed as: SIEG FRANK
9 granted patents·6 pending applications·1,530 citations·filing 2002–2020
89Inventor score
Files withCURONZ HOLDINGS COMPANY LTD6NEUREN PHARMACEUTICALS LTD4SIEG FRANK2BRIMBLE MARGARET ANNE1HARRIS PAUL WILLIAM RICHARD1
Top patents by PatentIndex Score
15 records- 0194US7563862B2Neural regeneration peptides and methods for their use in treatment of brain damageNEUREN PHARMACEUTICALS LTD·Filed 2004·Granted Jul 21, 2009·1.5k cites·28 claims
- 0289US7605177B2Effects of glycyl-2 methyl prolyl glutamate on neurodegenerationNEUREN PHARMACEUTICALS LTD·Filed 2005·Granted Oct 20, 2009·14 cites·13 claims
- 0386US8067425B2Neuroprotective bicyclic compounds and methods for their useBRIMBLE MARGARET ANNE·Filed 2004·Granted Nov 29, 2011·31 cites·3 claims
- 0484US7863304B2Analogs of glycyl-prolyl-glutamateNEUREN PHARMACEUTICALS LTD·Filed 2007·Granted Jan 4, 2011·8 cites·14 claims
- 0576US8309684B2Synthetic analogues of neural regeneration peptidesHARRIS PAUL WILLIAM RICHARD·Filed 2010·Granted Nov 13, 2012·3 cites·3 claims
- 0670US8138304B2Neural regeneration peptides and formulations thereofSIEG FRANK·Filed 2006·Granted Mar 20, 2012·4 cites·6 claims
- 0768US9040485B2Synthetic analogues of neural regeneration peptidesCURONZ HOLDINGS COMPANY LTD·Filed 2012·Granted May 26, 2015·2 cites·3 claims
- 0867US7767786B2Neural regeneration peptides and methods for their use in treatment of neural injury or degenerationNEUREN PHARMACEUTICALS LTD·Filed 2002·Granted Aug 3, 2010·3 cites·4 claims
- 0953US2017218023A1Synthetic analogues of neural regeneration peptidesCURONZ HOLDINGS COMPANY LTD·Filed 2017·Application pending·0 cites
- 1051US2016296590A1Method of treating or preventing epilepsy or seizures using one or more neural regeneration peptidesCURONZ HOLDINGS COMPANY LTD·Filed 2014·Application pending·0 cites
- 1150US9650418B2Synthetic analogues of neural regeneration peptidesCURONZ HOLDINGS COMPANY LTD·Filed 2015·Granted May 16, 2017·0 cites·7 claims
- 1247US2016015771A1Method of treating optic nerve damage, ophthalmic ischemia or ophthalmic reperfusion injuryCURONZ HOLDINGS COMPANY LTD·Filed 2013·Application pending·0 cites
- 1340US2016031937A1Neural regeneration peptides and uses thereforCURONZ HOLDINGS COMPANY LTD·Filed 2014·Application pending·0 cites
- 1439US2022280605A1A Composition And Method For Improving The Profile Of BloodMANUKAMED FUNCTIONAL FOODS LTD·Filed 2020·Application pending·0 cites
- 1536US2011306557A1Neural regeneration peptides and methods for their use in treatment of brain damageSIEG FRANK·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →